Pulse Biosciences, Inc. provided revenue guidance for the fourth quarter 2021. Preliminary unaudited full year 2021 revenue is expected to be in the range of $1.3 million to $1.4 million, including preliminary unaudited fourth quarter 2021 revenue of approximately $750,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.51 USD | -4.48% | +1.23% | -5.96% |
May. 20 | Pulse Biosciences Moves New Record Date for Rights Offering | MT |
May. 14 | Pulse Biosciences Appoints Burke Barrett as President, CEO | MT |
1st Jan change | Capi. | |
---|---|---|
-5.96% | 638M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- Pulse Biosciences, Inc. Provides Revenue Guidance for the Fourth Quarter 2021